Evoke
EVOK · Main Market · Travel and Leisure · mcap £194m today
All announcements
-
01 Oct 26Total Voting RightsRNS 9800180 ↗
-
29 Sep 26Holding(s) in CompanyRNS 9797271 ↗
-
24 Sep 26Holding(s) in CompanyRNS 9789825 ↗
-
24 Sep 26Holding(s) in CompanyRNS 9789819 ↗
-
18 Sep 26Results of Intralot General Meeting
On 5 June 2026, the board of Bally’s Intralot S.A.
RNS 9780475 ↗ -
16 Sep 26Holding(s) in CompanyRNS 9776075 ↗
-
10 Sep 26Holding(s) in CompanyRNS 9765660 ↗
-
01 Sep 26Total Voting RightsRNS 9747050 ↗
-
28 Aug 26Holding(s) in CompanyRNS 9745778 ↗
-
26 Aug 26Holding(s) in CompanyRNS 9741983 ↗
-
17 Aug 26Results of Court Meeting and General Meeting
On 5 June 2026, the board of Bally's Intralot S.A.
RNS 9725760 ↗ -
12 Aug 26H1 2026 Interim Results
Resilient underlying performance with decisive actions mitigating significant additional duties
RNS 9716727 ↗ -
03 Aug 26Total Voting RightsRNS 9699562 ↗
-
21 Jul 26
-
16 Jul 26Notice of Interim Results
evoke (LSE: EVOK), one of the world's leading betting and gaming companies with internationally renowned brands including William Hill, 888 and Mr Green, will announce its Interim Results for the six months ended 30 June 2026 on Wednesday 12 August at 7.00am BST.
RNS 9671318 ↗ -
08 Jul 26Holding(s) in CompanyRNS 9659410 ↗
-
03 Jul 26
-
01 Jul 26Total Voting RightsRNS 9645574 ↗
-
22 Jun 26Holding(s) in CompanyRNS 9630310 ↗
-
12 Jun 26Awards granted under the LTIP
Awards granted under the Long Term Incentive Plan ('LTIP')
RNS 9616768 ↗ -
09 Jun 26Director/PDMR Shareholding
Notification of Transactions by Persons Discharging Managerial Responsibilities
RNS 9609745 ↗ -
08 Jun 26Results of AGM 8 June 2026
evoke (LSE: EVOK), announces that at its Annual General Meeting (AGM), held today, 8 June 2026, ordinary resolutions numbers 1 to 13 and special resolutions 14 to 16 as set out in the Notice of Annual General Meeting dated 11 May 2026, were duly passed by...
RNS 9607038 ↗ -
05 Jun 26Recommended all-share acquisition of evoke plc Strategic review
("Intralot") and the board of evoke plc ("evoke") are pleased to announce that they have reached an agreement on the terms and conditions of a recommended all-share acquisition by Intralot of the entire issued, and to be issued, ordinary share capital of evoke.
RNS 9603066 ↗ -
04 Jun 26Holding(s) in CompanyRNS 9602959 ↗
-
01 Jun 26Total Voting RightsRNS 9593146 ↗
-
18 May 26Extension of Firm Offer Deadline Possible offer (Rule 2.4)
On 20 April 2026, evoke announced that it was in discussions with Bally's Intralot S.A.
RNS 9573950 ↗ -
11 May 26Publication of Notice of AGM
The Company has today published on its website, and posted to shareholders who have elected to receive a paper copy, the Notice of Annual General Meeting ("AGM") 2026 ("Notice").
RNS 9560475 ↗ -
01 May 26Total Voting Rights & CorrectionRNS 9547897 ↗
-
30 Apr 26FY25 Results
Significantly improved underlying profitability with FY25 Adjusted EBITDA +14% to £356m in line with expectations
RNS 9545320 ↗ -
28 Apr 26Delay to publication of FY25 audited results
evoke (LSE: EVOK), one of the world's leading betting and gaming companies with internationally renowned brands including William Hill, 888 and Mr Green, announces that the publication of its audited annual results for the year ended 31 December 2025,...
RNS 9542333 ↗ -
20 Apr 26Statement regarding media speculation
evoke notes the recent media speculation and confirms that it is in discussions with Bally's Intralot S.A.
RNS 9527171 ↗ -
14 Apr 26Block Listing Six Monthly ReturnRNS 9518082 ↗
-
01 Apr 26Total Voting RightsRNS 9503136 ↗
-
31 Mar 26Holding(s) in CompanyRNS 9501093 ↗
-
18 Mar 26Notice of FY25 Results Strategic review
evoke (LSE: EVOK), one of the world's leading betting and gaming companies with internationally renowned brands including William Hill, 888 and Mr Green, intends to announce its financial results for the year ended 31 December 2025 ("FY25") on Wednesday 29...
RNS 9479284 ↗ -
02 Mar 26Total Voting RightsRNS 9452038 ↗
-
02 Feb 26Total Voting RightsRNS 9399721 ↗
-
27 Jan 262025 Post-close Trading Update Strategic review
FY25 revenue growth of +2%; FY25 Adjusted EBITDA expected to be in line with market expectations
RNS 9388063 ↗ -
02 Jan 26Total Voting RightsRNS 9328788 ↗
-
18 Dec 25Notice of FY 2025 Trading Update
evoke (LSE: EVOK), one of the world's leading betting and gaming companies with internationally renowned brands including William Hill, 888 and Mr Green, will announce a post-close trading update for the three and 12 months ended 31 December 2025 on...
RNS 9305026 ↗ -
17 Dec 25Holding(s) in CompanyRNS 9304106 ↗
-
10 Dec 25Strategic Review Strategic review
Further to the Company's announcement on 26 November 2026, and following recent media speculation, the board of directors of the Company confirms it has decided to undertake a review of the Company's strategic options, which will include the consideration...
RNS 9287847 ↗ -
01 Dec 25Total Voting RightsRNS 9265850 ↗
-
26 Nov 25Response to the UK Budget
The Board believes that industry tax changes, which will begin to impact from April 2026, will result in thousands of industry-wide job losses and increase customer activity on the unregulated black-market, ultimately reducing the overall monetary amount...
RNS 9259510 ↗ -
03 Nov 25Total Voting RightsRNS 9207325 ↗
-
28 Oct 25Q3 2025 trading update
Continued execution against strategy; revenue growth of +5%; no change to FY25 Adjusted EBITDA expectations
RNS 9197700 ↗ -
21 Oct 25Directorate Change
The board of directors (the "Board") of evoke (LSE: EVOK) announces today that, after more than five years at the Company, Lord Jon Mendelsohn has informed the Board of his decision to step down as Chair and Non-Executive Director with immediate effect.
RNS 9183151 ↗ -
14 Oct 25Block Listing Six Monthly ReturnRNS 9168746 ↗
-
07 Oct 25Committee Update
In accordance with UKLR 6.4.6 the Company confirms that Sean Wilkins has been appointed to the Gaming Compliance Committee (" the Committee") and Mark Summerfield has been appointed as Chair of the Committee with immediate effect.
RNS 9154289 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.